Phase I, first-in-human trial of programmed cell death receptor-1 (PD-1) inhibitor, JTX-4014, in adult patients with advanced, refractory, solid tumors

por Papadopoulos, Kyriakos P., Lakhani, Nehal, Falchook, Gerald S., Riley, Gosia, Baeck, Johan, Brown, Karen S., Gordon, Gilad, Le, Lidya, Wang, Judy S.
Publicado 2020

Safety and Immunogenicity of M2-Deficient, Single Replication, Live Influenza Vaccine (M2SR) in Adults

por Eiden, Joseph, Gordon, Gilad, Fierro, Carlos, Herber, Renee, Aitchison, Roger, Belshe, Robert, Greenberg, Harry, Hoft, Daniel, Hatta, Yasuko, Moser, Michael J., Tary-Lehmann, Magdalena, Kawaoka, Yoshihiro, Neumann, Gabriele, Radspinner, Paul, Bilsel, Pamuk
Publicado 2021

1970. Phase 1 Clinical Trial of Intranasal Immunization with M2-Deficient, Single Replication, Live Influenza Vaccine (M2SR): Safety and Immune Response in Adults

por Eiden, Joseph, Gordon, Gilad, Fierro, Carlos, Belshe, Robert, Greenberg, Harry, Hoft, Dan, Hatta, Yasuko, Imboden, Michael, Moser, Mike, Herber, Renee, Boltz, David, Tary-Lehmann, Magdalena, Kawaoka, Yoshihiro, Neumann, Gabriele, Radspinner, Paul, Aitchison, Roger, Bilsel, Pamuk
Publicado 2018